News

AstraZeneca PLC AZN shares rallied 2.79% to £104.02 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.28% to 8,785.33 ...
Fresh concerns have emerged about the platelet studies underpinning the FDA approval of ticagrelor, AstraZeneca's multibillion-dollar heart drug. A new BMJ investigation reveals data ...
AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which would help the Anglo-Swedish drugmaker develop therapies for chronic ...
AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial intelligence-driven technology for discovering and developing novel oral drugs.
The pharmaceutical drug company AstraZeneca filed a lawsuit against the Utah attorney general claiming Utah's new law on limiting prescription drug prices goes against a federal program.
AstraZeneca CEO Pascal Soriot unpacks President Donald Trump's drug cost cut executive order on 'The Claman Countdown.' Elon Musk turns on Donald Trump just days after leaving the White House ...
A Google Translate screenshot correctly shows that the name of the pharmaceutical company AstraZeneca, when written as “A stra ze neca,” means “a road to death” in Latin.
A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while AstraZeneca leads on invention.
Pharmalittle: We’re reading about a Trump drug-pricing plan, an AstraZeneca court loss, and more The FDA announced a completed pilot for a generative AI-based system for speeding drug reviews ...
AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ongoing $3.5 billion investment in American innovation.
The facility is part of AstraZeneca's $3.5 billion investment in U.S. research and manufacturing. Mary Trump issues warning on long-term impact of Donald Trump move 6 Signs You Were Raised By A ...